• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞学正常女性中宫颈人乳头瘤病毒感染的患病率、感染情况及清除情况:夏威夷人乳头瘤病毒队列研究

Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study.

作者信息

Goodman Marc T, Shvetsov Yurii B, McDuffie Katharine, Wilkens Lynne R, Zhu Xuemei, Thompson Pamela J, Ning Lily, Killeen Jeffrey, Kamemoto Lori, Hernandez Brenda Y

机构信息

Epidemiology Program, Cancer Research Center of Hawaii and University Health Services, University of Hawaii, Honolulu, Hawaii 96813, USA.

出版信息

Cancer Res. 2008 Nov 1;68(21):8813-24. doi: 10.1158/0008-5472.CAN-08-1380.

DOI:10.1158/0008-5472.CAN-08-1380
PMID:18974124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2727731/
Abstract

Few natural history studies of cervical human papillomavirus (HPV) incidence and duration have been conducted among older women, especially from multiethnic populations. Viral and nonviral determinants of HPV acquisition and clearance were examined among 972 sexually active women, ages 18 to 85 years, recruited from clinics on Oahu, Hawaii, and followed for a mean duration of 15 months (range, 2-56 months). Interviews and cervical cell specimens for cytology and HPV DNA detection by PCR, using the PGMY09/PGMY11 primer system, were obtained at baseline and at 4-month intervals. The prevalence of cervical HPV infection was 25.6% at study entry. A total of 476 incident genotype-specific infections were observed during the follow-up period. The incidence of high-risk (HR) HPV types (9.26 per 1,000 woman-months) was similar to low-risk (LR) HPV types (8.24 per 1,000 woman-months). The most commonly acquired HR-HPV types were HPV-52, HPV-16, and HPV-31; and their incidence was increased significantly with a coexisting cervical HPV infection. Cervical HPV acquisition decreased with age, income, and long-term use of oral contraceptives and increased with number of sexual partners, use of hormonal creams, alcohol drinking, and condom use by a sexual partner. Cohort participants cleared 265 of the 476 incident infections during follow-up. LR-HPV infections cleared more rapidly than did HR-HPV infections (median, 180 days versus 224 days). Clearance times were enhanced among older women and women with multiple infections. Our data suggest several viral and nonviral determinants of cervical HPV acquisition and clearance that might be used in cervical cancer prevention programs.

摘要

针对老年女性,尤其是多民族人群中的宫颈人乳头瘤病毒(HPV)发病率和持续时间的自然史研究较少。在972名年龄在18至85岁的性活跃女性中,研究了HPV感染和清除的病毒及非病毒决定因素,这些女性是从夏威夷瓦胡岛的诊所招募的,平均随访时间为15个月(范围为2至56个月)。在基线和每隔4个月时进行访谈,并采集宫颈细胞样本用于细胞学检查以及使用PGMY09/PGMY11引物系统通过PCR检测HPV DNA。研究开始时宫颈HPV感染的患病率为25.6%。在随访期间共观察到476例基因型特异性感染病例。高危(HR)HPV类型的发病率(每1000女性 - 月9.26例)与低危(LR)HPV类型(每1000女性 - 月8.24例)相似。最常见的获得性HR - HPV类型为HPV - 52、HPV - 16和HPV - 31;并且在同时存在宫颈HPV感染时其发病率显著增加。宫颈HPV感染率随年龄、收入和长期口服避孕药的使用而降低,随性伴侣数量、激素乳膏的使用、饮酒以及性伴侣使用避孕套而增加。队列参与者在随访期间清除了476例感染病例中的265例。LR - HPV感染比HR - HPV感染清除得更快(中位数分别为180天和224天)。老年女性和多重感染女性的清除时间更长。我们的数据表明了几种可能用于宫颈癌预防计划的宫颈HPV感染和清除的病毒及非病毒决定因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a8e/2727731/1d125bd448b7/nihms96895f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a8e/2727731/0d3f45e87b26/nihms96895f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a8e/2727731/1d125bd448b7/nihms96895f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a8e/2727731/0d3f45e87b26/nihms96895f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a8e/2727731/1d125bd448b7/nihms96895f2.jpg

相似文献

1
Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study.细胞学正常女性中宫颈人乳头瘤病毒感染的患病率、感染情况及清除情况:夏威夷人乳头瘤病毒队列研究
Cancer Res. 2008 Nov 1;68(21):8813-24. doi: 10.1158/0008-5472.CAN-08-1380.
2
The influence of multiple human papillomavirus types on the risk of genotype-concordant incident infections of the anus and cervix: the Hawaii HPV cohort study.多种人乳头瘤病毒类型对肛门和宫颈基因型一致感染风险的影响:夏威夷 HPV 队列研究。
J Infect Dis. 2011 Feb 1;203(3):335-40. doi: 10.1093/infdis/jiq058. Epub 2010 Dec 20.
3
Duration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV cohort study.女性肛门人乳头瘤病毒(HPV)感染的持续时间和清除情况:夏威夷HPV队列研究
Clin Infect Dis. 2009 Mar 1;48(5):536-46. doi: 10.1086/596758.
4
Spectrum of genital human papillomavirus infection in a female adolescent population.女性青少年人群中生殖器人乳头瘤病毒感染的谱系
Sex Transm Dis. 1995 Jul-Aug;22(4):236-43. doi: 10.1097/00007435-199507000-00007.
5
Plasma micronutrients and the acquisition and clearance of anal human papillomavirus infection: the Hawaii HPV cohort study.血浆微量营养素与肛门人乳头瘤病毒感染的获得和清除:夏威夷 HPV 队列研究。
Cancer Res. 2010 Dec 1;70(23):9787-97. doi: 10.1158/0008-5472.CAN-10-1374. Epub 2010 Oct 8.
6
Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives.年轻女性宫颈人乳头瘤病毒6、11、16和18型感染的发病率及持续时间:多分析视角评估
Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):709-15. doi: 10.1158/1055-9965.EPI-06-0846.
7
Human papillomavirus cervical infection in Guarani Indians from the rainforest of Misiones, Argentina.来自阿根廷米西奥内斯雨林的瓜拉尼印第安人中的人乳头瘤病毒宫颈感染
Int J Infect Dis. 2004 Jan;8(1):13-9. doi: 10.1016/j.ijid.2003.03.001.
8
Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa.南非患有宫颈疾病的HIV-1阳性和阴性女性的宫颈和口腔人乳头瘤病毒类型
J Med Virol. 2008 Jun;80(6):953-9. doi: 10.1002/jmv.21166.
9
Distribution of various types of low-risk human papillomavirus according to cervical cytology and histology in northern Chinese women.中国北方女性中不同类型低风险人乳头瘤病毒根据宫颈细胞学和组织学的分布情况
Int J Gynaecol Obstet. 2014 Jul;126(1):28-32. doi: 10.1016/j.ijgo.2014.01.020. Epub 2014 Apr 3.
10
Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.人乳头瘤病毒E6/E7信使核糖核酸和人乳头瘤病毒脱氧核糖核酸检测法在中国宫颈病变女性中检测和筛查致癌性人乳头瘤病毒感染的诊断性能
Asian Pac J Cancer Prev. 2015;16(17):7633-40. doi: 10.7314/apjcp.2015.16.17.7633.

引用本文的文献

1
Why HPV16? Why, now, HPV42? How the discovery of HPV42 in rare cancers provides an opportunity to challenge our understanding about the transition between health and disease for common members of the healthy microbiota.为什么是16型人乳头瘤病毒(HPV16)?为什么现在又发现了42型人乳头瘤病毒(HPV42)?在罕见癌症中发现HPV42如何为我们提供了一个契机,去挑战我们对健康微生物群普通成员在健康与疾病之间转变的理解。
FEMS Microbiol Rev. 2024 Nov 23;48(6). doi: 10.1093/femsre/fuae029.
2
Forecasting Disease Burden with a Dynamic Transmission Model of Human Papillomavirus and Recurrent Respiratory Papillomatosis in the United States.美国基于人乳头瘤病毒和复发性呼吸道乳头瘤病动态传播模型的疾病负担预测。
Viruses. 2024 Aug 11;16(8):1283. doi: 10.3390/v16081283.
3

本文引用的文献

1
Acquisition of anal human papillomavirus (HPV) infection in women: the Hawaii HPV Cohort study.女性肛门人乳头瘤病毒(HPV)感染的获得情况:夏威夷HPV队列研究
J Infect Dis. 2008 Apr 1;197(7):957-66. doi: 10.1086/529207.
2
Acquisition of new infection and clearance of type-specific human papillomavirus infections in female students in Busan, South Korea: a follow-up study.韩国釜山女学生新感染的获得及特定类型人乳头瘤病毒感染的清除:一项随访研究
BMC Infect Dis. 2008 Jan 30;8:13. doi: 10.1186/1471-2334-8-13.
3
Human papillomavirus and cervical cancer.
p16 flow cytometry of exfoliated cervical cells: Its role in quantitative pathology and clinical diagnosis of squamous intraepithelial lesions.
巴氏涂片宫颈细胞的 p16 流式细胞术:在鳞状上皮内病变的定量病理学和临床诊断中的作用。
Clin Transl Med. 2023 Mar;13(3):e1209. doi: 10.1002/ctm2.1209.
4
Different human papillomavirus types share early natural history transitions in immunocompetent women.不同类型的人乳头瘤病毒在免疫功能正常的女性中具有相似的早期自然史转变。
Int J Cancer. 2022 Sep 15;151(6):920-929. doi: 10.1002/ijc.34128. Epub 2022 Jun 17.
5
Oncogenic human papillomavirus DNA in female sex workers of Bihar, India.印度比哈尔邦女性性工作者中的致癌性人乳头瘤病毒DNA
Int J Health Sci (Qassim). 2022 Mar-Apr;16(2):17-26.
6
Incidence and clearance of oral and cervicogenital HPV infection: longitudinal analysis of the MHOC cohort study.口腔和宫颈 HPV 感染的发生率和清除率:MHOC 队列研究的纵向分析。
BMJ Open. 2022 Jan 3;12(1):e056502. doi: 10.1136/bmjopen-2021-056502.
7
Human papillomavirus persistence or clearance after infection in reproductive age. What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite.人乳头瘤病毒在生殖年龄后的持续感染或清除。现状如何?文献复习和一种含硅酸钠、柠檬酸和亚硒酸盐的阴道凝胶的新数据。
Womens Health (Lond). 2021 Jan-Dec;17:17455065211020702. doi: 10.1177/17455065211020702.
8
Female Human Papillomavirus Infection Associated with Increased Risk of Infertility: A Nationwide Population-Based Cohort Study.女性人乳头瘤病毒感染与不孕风险增加相关:一项全国范围内基于人群的队列研究。
Int J Environ Res Public Health. 2020 Sep 7;17(18):6505. doi: 10.3390/ijerph17186505.
9
Determinants of Acquisition and Clearance of Human Papillomavirus Infection in Previously Unexposed Young Women.未暴露于 HPV 感染的年轻女性 HPV 感染获得和清除的决定因素。
Sex Transm Dis. 2019 Oct;46(10):663-669. doi: 10.1097/OLQ.0000000000001053.
10
16/18 genotyping in triage of persistent human papillomavirus infections with negative cytology in the English cervical screening pilot.16/18 基因分型在英国宫颈筛查试验中细胞学阴性的持续性人乳头瘤病毒感染中的分流作用。
Br J Cancer. 2019 Sep;121(6):455-463. doi: 10.1038/s41416-019-0547-x. Epub 2019 Aug 14.
人乳头瘤病毒与宫颈癌
Lancet. 2007 Sep 8;370(9590):890-907. doi: 10.1016/S0140-6736(07)61416-0.
4
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.细胞学正常女性宫颈人乳头瘤病毒DNA的全球流行率及基因型分布:一项荟萃分析
Lancet Infect Dis. 2007 Jul;7(7):453-9. doi: 10.1016/S1473-3099(07)70158-5.
5
Hawaii cohort study of serum micronutrient concentrations and clearance of incident oncogenic human papillomavirus infection of the cervix.夏威夷血清微量营养素浓度与宫颈致癌性人乳头瘤病毒感染清除情况的队列研究。
Cancer Res. 2007 Jun 15;67(12):5987-96. doi: 10.1158/0008-5472.CAN-07-0313. Epub 2007 Jun 6.
6
Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives.年轻女性宫颈人乳头瘤病毒6、11、16和18型感染的发病率及持续时间:多分析视角评估
Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):709-15. doi: 10.1158/1055-9965.EPI-06-0846.
7
Prevalence of HPV infection among females in the United States.美国女性人乳头瘤病毒(HPV)感染率
JAMA. 2007 Feb 28;297(8):813-9. doi: 10.1001/jama.297.8.813.
8
Variations in the age-specific curves of human papillomavirus prevalence in women worldwide.全球女性人乳头瘤病毒患病率特定年龄曲线的差异。
Int J Cancer. 2006 Dec 1;119(11):2677-84. doi: 10.1002/ijc.22241.
9
Chapter 5: Updating the natural history of HPV and anogenital cancer.第5章:更新人乳头瘤病毒与肛门生殖器癌的自然史
Vaccine. 2006 Aug 31;24 Suppl 3:S3/42-51. doi: 10.1016/j.vaccine.2006.06.018. Epub 2006 Jun 23.
10
Human papillomavirus infections with multiple types and risk of cervical neoplasia.多种类型的人乳头瘤病毒感染与宫颈肿瘤形成风险
Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1274-80. doi: 10.1158/1055-9965.EPI-06-0129.